Screener
Krystal Biotech, Inc. KRYS Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
| (in thousands, except per share data) | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Foreign currency translation | (1,182) | 236 |
| Comprehensive income | $53,173 | $36,313 |
| Net income per common share: | ||
| Basic | $1.91 | $1.24 |
| Diluted | $1.83 | $1.20 |
| Weighted-average common shares outstanding: | ||
| Basic | 29,288 | 28,815 |
| Diluted | 30,507 | 29,871 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Krystal Biotech, Inc.'s shares (diluted)?
- Krystal Biotech, Inc. (KRYS) reported shares (diluted) of 30.5M in Q1 2026.
- How has Krystal Biotech, Inc.'s shares (diluted) changed year-over-year?
- Krystal Biotech, Inc.'s shares (diluted) increased by 2.1% year-over-year, from 29.9M to 30.5M.
- What is the long-term trend for Krystal Biotech, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s shares (diluted) has grown at a 8.0% compound annual growth rate (CAGR), from 87.9M to 119.4M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Krystal Biotech, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude